Galderma adds more Asia Pacific markets after China and Australia
Galderma is expanding Alastin across the JPAC region, with launches in Taiwan, Japan, Singapore and South Korea after earlier rollouts in China and Australia.
Taiwan has already launched the premium regenerative skincare brand. Japan will follow soon. Singapore is scheduled for September, while South Korea is planned for November.
Galderma, which trades on SIX under the ticker GALD, announced the regional push from Zug, Switzerland. The company linked the move to its long-term investment in JPAC.
Japan and the wider Asia Pacific region rank among the fastest-growing markets for medical aesthetics and dermatological skincare. Rising use of minimally invasive procedures and a stronger focus on skin quality are driving that growth.
According to Galderma, demand is rising for products that support skin readiness, recovery and long-term results around energy-based device treatments and injectables.
Alastin targets that market with peri-procedural support products and daily skincare. The range is designed to boost the skin’s natural regenerative abilities and improve visible outcomes after aesthetic treatment.
Restorative Skin Complex with TriHex+
Select products use proprietary TriHex Technology. Galderma says the peptide blend helps clear aged, damaged collagen and elastin while supporting the production of new, healthy collagen and elastin.
Restorative Skin Complex with TriHex+ marks the next step in that platform. It supports the skin’s natural production of high molecular weight hyaluronic acid, while also increasing collagen and elastin production.
Nine products are included in the regional rollout. Procedure support items are Skin Nectar and INhance. Daily treatment products are Restorative Skin Complex with TriHex+, Restorative Eye Complex with TriHex Technology and Restorative Neck Complex with TriHex Technology.
The lineup also includes C-RADICAL Defence, A-LUMINATE Brightening Serum and HA IMMERSE Serum, plus Ultra Nourishing Moisturizer with TriHex Technology.
Dr. Rieko Tsubouchi, dermatologist and director of Ginza Skin Clinic in Japan, said patients now want skincare that goes beyond surface hydration. “They seek products that support skin function, renewal, and long-term skin quality.”
Alastin has more than 60 international dermatological publications and over 25 granted patents. In the United States, Galderma says it is the number one peri-procedural skincare brand.
Following the launches in China and Australia, Galderma is pushing further into a region known for advanced skincare practices and rapid growth in injectable aesthetics.
